PFS
Showing 26 - 50 of >10,000
free Survival and Evaluate Participant Experience for Metastatic
Active, not recruiting
- Anaplastic Lymphoma Kinase-positive
- Carcinoma Non-small-cell Lung
- Brigatinib
- +4 more
-
Maynard, MassachusettsEmpiraMed, Inc.
Feb 28, 2022
Extensive-Stage Small-Cell Lung Cancer Trial in Shanghai (durvalumab + anlotinib, Durvalumab)
Recruiting
- Extensive-Stage Small-Cell Lung Cancer
- durvalumab + anlotinib
- Durvalumab
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Nov 1, 2021
Urothelial Carcinoma, Bladder Cancer Trial in Houston (Abiraterone acetate, Durvalumab, Methotrexate)
Recruiting
- Urothelial Carcinoma
- Bladder Cancer
- Abiraterone acetate
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jun 2, 2022
Disorder of Consciousness Trial in Ottignies, Liège (Apomorphine Hydrochloride 50Mg/10mL Prefilled Syringe)
Active, not recruiting
- Disorder of Consciousness
- Apomorphine Hydrochloride 50Mg/10mL Prefilled Syringe
-
Ottignies, Brabant Wallon, Belgium
- +1 more
Feb 8, 2022
Psoriasis Trial in Australia, New Zealand (Stelara PFS)
Completed
- Psoriasis
- Stelara PFS
-
Brisbane, Australia
- +3 more
May 20, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +7 more
- Blinatumomab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2022
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Trial in United States
Suspended
- Acute Myeloid Leukemia
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- Cytarabine
- +2 more
-
Los Angeles, California
- +5 more
Dec 10, 2022
Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)
Not yet recruiting
- Localized Osteosarcoma
- +3 more
- Bone Scan
- +7 more
- (no location specified)
Jan 18, 2023
Progress Free Survival (PFS) and Overall Survival (OS) Trial in Guangzhou (Bevacizumab Injection, Nivolumab)
Completed
- Progress Free Survival (PFS) and Overall Survival (OS)
- Bevacizumab Injection
- Nivolumab
-
Guangzhou, Guangdong, ChinaFuda Cnacer Hospital
Sep 1, 2021
Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ph+ Acute Lymphoblastic Leukemia Trial in Chicago (Inotuzumab ozogamicin,
Recruiting
- Lymphoblastic Leukemia
- +2 more
- Inotuzumab ozogamicin
- +7 more
-
Chicago, IllinoisUniversity of Chicago Medical Center
May 16, 2022
Disorder of Consciousness Trial in Worldwide (Apomorphine HCl 5mg/ml Pre-filled Syringe (APO-go PFS 10ml), Sodium chloride
Recruiting
- Disorder of Consciousness
- Apomorphine hydrochloride 5mg/ml Pre-filled Syringe (APO-go PFS 10ml)
- Sodium chloride 9mg/ml
-
Liege, Belgium
- +4 more
Mar 29, 2022
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia
Recruiting
- Acute Myeloid Leukemia
- +3 more
- Cytarabine
- +4 more
-
Birmingham, Alabama
- +8 more
Jan 24, 2023
Anemia of Chronic Kidney Disease Trial in Buenos Aires, Caba, Asunción (Erythropoietin alfa)
Unknown status
- Anemia of Chronic Kidney Disease
- Erythropoietin alfa
-
Buenos Aires, Argentina
- +10 more
Jan 26, 2021
T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)
Recruiting
- T Acute Lymphoblastic Leukemia
- T Lymphoblastic Lymphoma
- Cyclophosphamide
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Jan 11, 2023
Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative Trial in Houston (Doxorubicin,
Recruiting
- Metastatic Kidney Medullary Carcinoma
- +4 more
- Doxorubicin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2023
Stage I Mantle Cell Lymphoma, Stage II Contiguous Mantle Cell Lymphoma, Stage II Non-Contiguous Mantle Cell Lymphoma Trial in
Active, not recruiting
- Stage I Mantle Cell Lymphoma
- +4 more
- Autologous Hematopoietic Stem Cell Transplantation
- +8 more
-
Buffalo, New York
- +1 more
Mar 9, 2022
Adhesive Capsulitis Trial in Islamabad (Post facilitation stretch, Active release technique)
Completed
- Adhesive Capsulitis
- Post facilitation stretch
- Active release technique
-
Islamabad, Punjab, PakistanAsif Hospital Wah Cantt
Mar 22, 2021
KRAS Gene Mutation, Metastatic Malignant Tumor in the Brain, Recurrent Non-Small Cell Lung Carcinoma Trial in Palo Alto
Active, not recruiting
- KRAS Gene Mutation
- +3 more
- Methotrexate
- +2 more
-
Palo Alto, CaliforniaStanford University School of Medicine
Feb 9, 2022
Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, Solid Tumor Trial in New Brunswick
Active, not recruiting
- Ann Arbor Stage III Non-Hodgkin Lymphoma
- +2 more
- Cyclophosphamide
- +4 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 28, 2023
Esophageal Cancer, Gastroesophageal Junction Cancer, Anastomotic Leak Trial in Guangzhou (Porcine Fibrin Sealant (PFS), Surgery)
Completed
- Esophageal Cancer
- +2 more
- Porcine Fibrin Sealant (PFS)
- Surgery
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 22, 2021
Follicular Lymphoma, Small Lymphocytic Lymphoma, Marginal Zone Lymphoma Trial in United States (dietary supplement, biological,
Active, not recruiting
- Follicular Lymphoma
- +3 more
- Vitamin D
- +2 more
-
Miami, Florida
- +6 more
Mar 6, 2022
PFS and OS of Advanced Neuroendocrine Cancer After Systemic
Recruiting
- Neuroendocrine Tumors
-
Olsztyn, Warmińsko-Mazurskie, Poland
- +1 more
May 12, 2021
Malaria,Falciparum Trial in Oxford (Pfs25-IMX313/Matrix-M1)
Terminated
- Malaria,Falciparum
- Pfs25-IMX313/Matrix-M1
-
Oxford, United KingdomCCVTM, University of Oxford, Churchill Hospital
Sep 25, 2020
Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in Springfield,
Active, not recruiting
- Age-Related Macular Degeneration
- +4 more
- bevacizumab
-
Springfield, Illinois
- +2 more
Dec 6, 2021